Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan-Reference-Cited by-同舟云学术

Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan

Published:2019-10-22 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chen Der-Yuan,Yu Fun,Tuan Li-Wen,Tang Chao-Hsiun

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis;Arnett;Arthritis Rheum,1988

2. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies;Avina-Zubieta;Ann. Rheum. Dis.,2012

3. Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis;Barnabe;Arthritis Care Res. (Hoboken),2011

4. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis;Betts;Clin. Ther.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of treating rheumatoid arthritis in the primary care public health system in Ireland: A time-driven activity-based cost analysis;Exploratory Research in Clinical and Social Pharmacy;2024-06

2. Projecting direct medical costs and productivity benefits of improving access to advanced therapy for rheumatoid arthritis: a projection modelling study;Journal of Market Access & Health Policy;2023-02-08

3. The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis;Journal of Clinical Medicine;2022-12-22

4. Disease Markers and Therapeutic Targets for Rheumatoid Arthritis Identified by Integrating Bioinformatics Analysis with Virtual Screening of Traditional Chinese Medicine;Frontiers in Bioscience-Landmark;2022-09-28

5. An overview of immune checkpoint therapy in autoimmune diseases;International Immunopharmacology;2022-06